Peter Herrlich

from Wikipedia, the free encyclopedia

Peter Herrlich (born November 10, 1940 in Munich ) is a German molecular and tumor biologist. Professor emeritus in Jena is Herrlich and headed the Leibniz Institute for Aging Research from 2003 to 2011 .

After studying medicine at the Ludwig Maximilians University in Munich , he completed his habilitation in biochemistry and molecular biology at the Free University of Berlin . After research stays in the USA (Chicago, New York), he headed a working group at the MPI in Berlin before he was appointed Professor of Genetics at the University of Karlsruhe in 1977 and headed the Genetics Department of the Institute of Genetics and Toxicology at the Karlsruhe Research Center for decades . In 2003 he became Professor of Molecular Genetics at the Friedrich Schiller University in Jena and Director of the Leibniz Institute for Aging Research, whose reorientation towards biomedical aging research he initiated.

He dealt in particular with the relationship between aging and cancer development and the processes of cell division and cell migration that are important in both areas (metastasis in tumors).

A research focus for many years is the sometimes controversial importance of individual CD44 splice variants in tumor progression and metastasis, which has not yet led to any therapeutic approach.

Awards and honors

Web links

Individual evidence

  1. ↑ Directory of members: Peter Herrlich. Academia Europaea, accessed June 28, 2017 .